Pluristem Therapeutics to Deliver Two Presentations During Israel’s Largest Biotech Conference: IATI-BioMed

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HAIFA, Israel, June 10, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that Pluristem’s CEO and its Project Innovation Research Manager will be delivering two different presentations during Israel’s largest biotechnology conference, the 12th Annual IATI-BioMed Conference June 10th through 12th, 2013 in Tel Aviv.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC